cabergoline has been researched along with letrozole in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Apaydın, N; Cengiz, H; Eskicioğlu, F; Genç, M; Şahin, N; Sivrikoz, ON; Töz, E; Turan, GA | 1 |
| Gharabaghi, PM; Mobasseri, M; Ouladsahebmadarek, E; Rahmani, V; Sayyah-Melli, M | 1 |
| Fatemi, F; Jouhari, S; Khazali, S; Lakpour, N; Mirzadegan, E; Mohammadi, Z; Mohammadzadeh, A; Mohazzab, A; Naderi, MM; Soltanghoraee, H; Zafardoust, S | 1 |
1 review(s) available for cabergoline and letrozole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for cabergoline and letrozole
| Article | Year |
|---|---|
Comparison of the effects of letrozole and cabergoline on vascular permeability, ovarian diameter, ovarian tissue VEGF levels, and blood PEDF levels, in a rat model of ovarian hyperstimulation syndrome.
Topics: Animals; Cabergoline; Capillary Permeability; Chorionic Gonadotropin; Ergolines; Eye Proteins; Female; Gonadotropins, Equine; Humans; Letrozole; Nerve Growth Factors; Nitriles; Ovarian Hyperstimulation Syndrome; Ovary; Pregnancy; Prospective Studies; Rats; Rats, Wistar; Serpins; Triazoles; Vascular Endothelial Growth Factor A | 2016 |
Comparing the effect of aromatase inhibitor (letrozole) + cabergoline (Dostinex) and letrozole alone on uterine myoma regression,a randomized clinical trial.
Topics: Adult; Antineoplastic Agents; Aromatase Inhibitors; Cabergoline; Drug Therapy, Combination; Ergolines; Female; Humans; Leiomyoma; Letrozole; Middle Aged; Nitriles; Triazoles; Uterine Neoplasms; Uterus | 2017 |
2 other study(ies) available for cabergoline and letrozole
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effects of silymarin, cabergoline and letrozole on rat model of endometriosis.
Topics: Animals; Antioxidants; Aromatase Inhibitors; Cabergoline; Disease Models, Animal; Dopamine Agonists; Endometriosis; Female; Letrozole; Random Allocation; Rats; Rats, Sprague-Dawley; Silymarin; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2018 |